| |
| |
|
| Insider
Information: |
Simpson Curran |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
123,327 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,769,742 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
123,327 |
|
|
| Total
Value |
$1,769,742 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Sr. VP, Operations |
2012-07-30 |
0 |
2007-03-10 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2024-01-02 |
123,327 |
2016-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-10-16 |
4 |
OE |
$13.09 |
$1,314,223 |
D/D |
62,309 |
42,167 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-02-05 |
4 |
OE |
$13.09 |
$1,070,658 |
D/D |
43,832 |
83,332 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-05 |
4 |
OE |
$13.09 |
$92,886 |
D/D |
5,137 |
28,285 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$601,578 |
D/D |
(42,216) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• • – |
2012-07-30 |
4/A |
D |
$14.25 |
$375,260 |
D/D |
(26,334) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2009-08-06 |
4 |
S |
$14.55 |
$1,298,329 |
D/D |
(88,955) |
11,112 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2024-01-02 |
4 |
D |
$17.95 |
$145,754 |
D/D |
(8,120) |
84,865 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-10 |
4 |
OE |
$19.50 |
$858,098 |
D/D |
31,660 |
54,308 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-07 |
4 |
OE |
$19.50 |
$101,108 |
D/D |
5,185 |
22,933 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-12 |
4 |
OE |
$19.50 |
$33,150 |
D/D |
1,700 |
19,448 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-14 |
4 |
OE |
$19.50 |
$395,498 |
D/D |
11,612 |
29,360 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-12-22 |
4 |
OE |
$22.00 |
$660,000 |
D/D |
30,000 |
69,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-03-13 |
4 |
OE |
$22.00 |
$550,000 |
D/D |
25,000 |
64,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-11-16 |
4 |
OE |
$22.00 |
$723,404 |
D/D |
32,882 |
72,382 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-05-28 |
4 |
OE |
$22.00 |
$396,000 |
D/D |
18,000 |
57,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-11 |
4 |
OE |
$22.00 |
$145,926 |
D/D |
6,633 |
16,512 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2023-01-03 |
4 |
D |
$22.68 |
$47,084 |
D/D |
(2,076) |
25,040 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-06-11 |
4 |
AS |
$26.07 |
$481,204 |
D/D |
(18,461) |
25,281 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-06-01 |
4 |
AS |
$27.11 |
$620,960 |
D/D |
(22,904) |
45,790 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2009-11-30 |
4 |
AS |
$27.37 |
$1,010,583 |
D/D |
(36,923) |
11,112 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-08-25 |
4 |
AS |
$28.00 |
$516,908 |
D/D |
(18,461) |
25,281 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-04-29 |
4 |
AS |
$28.99 |
$812,029 |
D/D |
(28,015) |
45,790 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-03-10 |
4 |
D |
$29.03 |
$101,344 |
D/D |
(3,491) |
21,790 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-02-16 |
4 |
AS |
$29.10 |
$873,102 |
D/D |
(30,000) |
11,112 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-11-27 |
4 |
AS |
$29.31 |
$58,620 |
D/D |
(2,000) |
39,500 |
0 |
- |
|
73 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
